Archon Capital Management LLC Vericel Corp Transaction History

Archon Capital Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$14.68 - $19.12 $1.65 Million - $2.14 Million	-112,130 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$8.5 - $15.82 $5.77 Million - $10.7 Million	-679,228 Reduced 85.83%	112,130 $1.55 Million
Q1 2020 May 15, 2020	BUY	$7.25 - $19.22 $2.46 Million - $6.52 Million	339,156 Added 75.0%	791,358 $7.26 Million
Q4 2019 Feb 13, 2020	SELL	$13.77 - $19.2 $50,949 - $71,040	-3,700 Reduced 0.81%	452,202 $7.87 Million
Q3 2019 Nov 14, 2019	SELL	$14.93 - $19.83 $321,816 - $427,435	-21,555 Reduced 4.51%	455,902 $6.9 Million
Q2 2019 Aug 14, 2019	SELL	$15.01 - $18.89 $3.26 Million - $4.1 Million	-217,002 Reduced 31.25%	477,457 $9.02 Million
Q1 2019 May 15, 2019	SELL	$16.23 - $20.29 $4.42 Million - $5.52 Million	-272,259 Reduced 28.16%	694,459 $12.2 Million
Q4 2018 Feb 14, 2019	SELL	$10.77 - $18.44 $11.9 Million - $20.3 Million	-1,100,659 Reduced 53.24%	966,718 $16.8 Million
Q3 2018 Nov 14, 2018	BUY	$9.1 - $14.8 $1.11 Million - $1.8 Million	121,500 Added 6.24%	2,067,377 $29.3 Million
Q2 2018 Aug 14, 2018	SELL	$9.6 - $14.6 $4.28 Million - $6.51 Million	-445,685 Reduced 18.64%	1,945,877 $18.9 Million
Q1 2018 May 11, 2018	SELL	$5.7 - $12.3 $4.78 Million - $10.3 Million	-838,215 Reduced 25.95%	2,391,562 $23.8 Million
Q4 2017 Feb 09, 2018	BUY	$3.65 - $5.98 $2.24 Million - $3.66 Million	612,773 Added 23.42%	3,229,777 $17.6 Million
Q3 2017 Nov 09, 2017	BUY	$3.0 - $6.0 $7.85 Million - $15.7 Million	2,617,004	2,617,004 $15.7 Million

277

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.73B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Archon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Archon Capital Management LLC with notifications on news.